MedTrace Logo

Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment

NCT01245894 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2010-11-23

No results posted yet for this study

Summary

The aim of this study was to measure the effect of low- and high-dose lipid-lowering treatment with rosuvastatin on the coronary physiology parameters.

Conditions

  • Myocardial Infarction [C14.907.585.500]

Interventions

DRUG

Low-dose Rosuvastatin

Rosuvastatin 5mg/day for one year

DRUG

High-dose Rosuvastatin

Rosuvastatin 40mg/day for one year

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Rasmus Egede, MD · Department of Cardiology, Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-06-30
Completion
2010-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245894 on ClinicalTrials.gov